BayCare Health System to Present on Improved Pharmacy Operations Using DoseMeRx and Cerner Electronic Health Record at Cerner...
September 24 2019 - 8:00AM
Tabula Rasa HealthCare, Inc. (TRHC) (Nasdaq: TRHC), a healthcare
technology company advancing the field of medication safety, today
announced its subsidiary DoseMe and BayCare Health System will
present at the Cerner Health Conference (CHC) 2019, an annual event
featuring the latest innovations in health care. BayCare Health
System will share their experiences using DoseMeRx within the
Cerner Millennium® electronic health record (EHR), which supports
improved pharmacy operations related to vancomycin dosing, an
antibiotic used to treat a range of infections.
Cerner Corporation (Nasdaq: CERN), a global
health platform and innovation company, will host this year’s
conference October 7-9 in Kansas City, Missouri. DoseMe and BayCare
Health System will join health care professionals from around the
world who gather at CHC each year to stay ahead of the curve on new
and existing technology."The impact of DoseMeRx integrated within
the EHR has been eye-opening,” said Charles Cornish, CEO, DoseMe.
“Drugs of a narrow therapeutic range that require ongoing drug
monitoring are notoriously difficult to dose. DoseMeRx really is
bringing confidence, rigor and operational efficiency to the
complex world of dosing. BayCare's commitment to innovation and
continually advancing their pharmacy and operations, in this case
with DoseMeRx and Cerner, is a testament to their commitment to
improving outcomes for their patients."
The interactive session will be led by Joseph Walton, PharmD,
MS, BCPS, Pharmacy Informatics Coordinator, BayCare Health System -
East Region, and Joanna Caranante, PharmD, BCPS, Residency Program
Director, St. Joseph's Hospital, BayCare Health System. They will
discuss how pharmacists at the hospital implemented Area Under the
Curve (AUC)-based dosing guidelines for vancomycin, one of the most
commonly used hospital antibiotics documented in the EHR. By using
SMART on FHIR technologies to integrate clinical data, they were
able to reduce pharmacy workload from 20 calculations and ordering
multiple drug levels to as few as three clicks and a single drug
level.
“The new draft consensus vancomycin guidelines
suggest the preferred approach to monitor AUC involves the use of
Bayesian dosing decision-support programs, such as DoseMeRx. For
our team, it’s critical that decision support is integrated into
our workflow in the EHR to ensure widespread and regular clinical
usage,” said Walton, “The Cerner Health Conference is a
perfect opportunity to demonstrate how we deployed DoseMeRx within
the Cerner EHR and optimized vancomycin dosing for thousands of
patients in just a couple of months.”
DoseMe team will demonstrate how easily DoseMeRx
optimizes the dosing of vancomycin and much more in the Cerner ERH
at booth 322 at the Conference.
To follow CHC, visit The Cerner Blog for posts on speakers and
sessions or follow along on Facebook, Instagram, LinkedIn
and Twitter for a behind-the-scenes look at the conference.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) is a leader in providing
patient-specific, data-driven technology and solutions that enable
healthcare organizations to optimize performance to improve patient
outcomes, reduce hospitalizations, lower healthcare costs and
manage risk. Medication risk management is TRHC’s lead
offering, and its cloud-based software applications, including
EireneRx® and MedWise™, provide solutions for a range of payers,
providers and other healthcare
organizations. www.tabularasahealthcare.com.
About DoseMe
DoseMe is a Tabula Rasa HealthCare Company (Nasdaq:TRHC) and the
first company in the world to develop precision dosing software -
DoseMeRx - developed specifically for clinical practice. DoseMe's
clinical decision support solutions focus on empowering healthcare
providers to optimize dosing of high-risk parenteral medications to
streamline operations, reduce adverse drugs events, decrease costs
and improve patient outcomes. For more information, visit
doseme-rx.com
About BayCare Health
BayCare offers a wide range of programs and services to meet the
health care needs of individuals and communities throughout
Florida. Our goal is to offer exceptional service at every level
and in many forms. Whether you require emergency surgery, prenatal
counseling, or outpatient imaging, you can always turn to BayCare
as your single trusted source for comprehensive care. We are proud
to be known throughout the Tampa Bay and Central Florida regions
for our not-for-profit hospitals, in addition to more than 300
facilities offering healthcare services.
Forward-Looking StatementsThis press release
includes forward-looking statements that we believe to be
reasonable as of today’s date, including statements regarding
Medication Risk Mitigation technology. Such statements are
identified by use of the words “anticipates,” “believes,”
“estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,”
“should,” and similar expressions. These forward-looking
statements are based on management’s expectations and assumptions
as of the date of this press release. Actual results might
differ materially from those explicit or implicit in the
forward-looking statements. Important factors that could cause
actual results to differ materially include: the need to innovate
and provide useful products and services; risks related to changing
healthcare and other applicable regulations; increasing
consolidation in the healthcare industry; managing our growth
effectively; our ability to adequately protect our intellectual
property; and the other risk factors set forth from time to time in
our filings with the SEC, including those factors discussed
under the caption “Risk Factors” in our most recent annual report
on Form 10-K, filed with the SEC on March 1, 2019, and in
subsequent reports filed with or furnished to the SEC, copies of
which are available free of charge within the Investor Relations
section of the TRHC website http://ir.trhc.com or upon request from
our Investor Relations Department. Any forward-looking statement
speaks only as of the date on which it was made. TRHC assumes no
obligation and does not intend to update these forward-looking
statements, except as required by law, to reflect events or
circumstances occurring after today’s date.
Media ContactDianne Semingsondsemingson@trhc.comT:
(215) 870-0829 |
Investors Bob East or Asher Dewhurst
Westwicke Partners tabularasa@westwicke.com T: (443) 213-0500 |
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Sep 2023 to Sep 2024